Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae

Circulation

Volumn 101, Issue 15, 2000, Pages 1760-1763

  Kothe, H ^b   Dalhoff, K ^a   Rupp, J ^b   Muller A ^b   Kreuzer, J ^b   Maass, M ^b   Katus, H A ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

Atherosclerosis; Endothelium; Infection; Inflammation

Indexed keywords

CERIVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN RADICAL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHLAMYDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INFECTION RATE; INFLAMMATION; MACROPHAGE; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0034681953     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.15.1760     Document Type: Article

References (11)

1. Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and aortic smooth muscle cells. Infect Immun. 1996;64:1614-1620.
2. Redecke V, Dalhoff K, Bohnet S, et al. Interaction of Chlamydia pneumoniae and human alveolar macrophages and inflammatory response. Am J Respir Cell Mol Biol. 1998;19:721-727.
3. Moazed TC, Kuo C, Grayston T. Evidence of systemic dissemination of C. pneumoniae via macrophages in the mouse. J Infect Dis. 1997;177: 1322-1325.
4. Capers Q, Alexander RW, Lou P, et al. Monocyte chemoattractant protein-1 in aortic tissues of hypertensive rats. Hypertension. 1997;30: 1397-1402.
5. Maass M, Bartels C, Engel PM, et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998;31:827-832.
6. Rosenson RS, Tangney CC, Casey CL. Inhibition of proinflammatory cytokine production by pravastatin. Lancet. 1999;353:983-984.
7. Jaffe EA, Nachmann NL, Becker CG, et al. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973;52:2745-2756.
8. Gabriel C, Tanner A. Transcription factor binding assays on 96-well plates. Tools Tech. 1997:36.
9. Brand K, Page S, Walli AK, et al. Role of NF-kappa B in atherogenesis. Exp Physiol. 1997;82:297-304.
10. De Bont N, Netea MG, Rovers C, et al. LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors. Atherosclerosis. 1998;139:147-152.
11. Goldstein JL, Brown MS. Regulation of mevalonate pathway. Nature. 1990;343:425-430.